Toggle light / dark theme

Joe Betts Lacroix – Entrepreneurial Focuses on Aging

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union, New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Joe Betts Lacroix of Y Combinator and Vium discusses the different ways in which entrepreneurs can focus on overcoming the diseases of aging, namely direct, indirect, and money-first approaches, and the strengths and weakness of each.

Joe was the primary technical founder of hardware/software startup OQO, which entered the Guinness Book of World Records for building the smallest fully featured PC. His experience spans from biotech research to electronics design. Very experienced in invention, prosecution and monetization of intellectual property, he has over 80 patents granted and pending in fields ranging from biophysics and safety systems to antennas, thermal systems, user interfaces, and analog electronics. He has written numerous peer-reviewed publications in fields such as biophysics, genetics, electronics, and robotics. Joe holds a Harvard A.B., an MIT S.M. and a Caltech research fellowship.

Humans beings on the brink of IMMORTALITY, top scientist claims

Two of the methods he said humans might use were “body part renewal” and linking bodies with machines so that people are living their lives through an android.

But after Dr Pearson’s predictions, immortality may now be a step nearer following the launch of a new start-up.

Human is hoping to make the immortality dream a reality with an ambitious plan.

Dr. James Peyer – A Portfolio Approach To Longevity

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Dr. James Peyer is the founder and Managing Partner of Apollo Ventures, an early-stage life science investor and company builder that focuses on breakthrough technologies for treating age-related diseases.

He discusses the strategic paths to bringing longevity-promoting therapeutics to market as quickly as possible, with a particular focus on engaging pharmaceutical companies via disease-focused, proof-of-concept trials.

The Longevity Project: Surprising Discoveries for Health and Long Life from the Landmark Eight-Decade Study: Howard S. Friedman, Leslie R. Martin: 9780452297708: Amazon.com: Books

“An extraordinary eighty-year study has led to some unexpected discoveries about long life.”

-O, The Oprah Magazine

For years we have been told to obsessively monitor when we’re angry, what we eat, how much we worry, and how often we go to the gym. So why isn’t everyone healthy? Drawing from the most extensive study of long life ever conducted, The Longevity Project busts many long- held myths, revealing how:

Startups in the Aging Sector — Ending Age-Related Diseases 2018

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Dr. Oliver Medvedik, LEAF vice president and Director of the Maurice Kanbar Center for Biomedical Engineering at the Cooper Union, chaired a panel with a focus on starting up biotech companies and dealing with the challenges inherent to launching a company in this industry.

Undoing Aging 2019 is on the horizon

It will be our second conference totally focussed on the science of actual human rejuvenation therapies to repair the damage of aging.


We are happy to begin introducing the speakers, starting with Dr. Jerry Shay.

Dr. Shay is the Vice Chairman of the Department of Cell Biology at The University of Texas Southwestern Medical Center in Dallas. Dr. Shay´s work on the relationships of telomeres and telomerase to aging and cancer is well recognized.

“Jerry has been a stalwart supporter of the SENS concept for well over a decade, and a world leader in the telomere biology field for much longer than that. He spoke at the very first SENS conference, back in 2003, and it will be a joy to welcome him again.” says Aubrey de Grey.

Ask LEAF Anything

Today is our first Ask LEAF Anything where you can ask us questions about our work in the rejuvenation biotechnology field.

https://www.leafscience.org/

In 2014, the Life Extension Advocacy Foundation was established as a 501©(3) non-profit organization dedicated to promoting healthy human lifespan through fiscally sponsoring longevity research projects and raising awareness regarding the societal benefits of healthy life extension.